Abnormalities in autonomic function in obese boys at-risk for insulin resistance and obstructive sleep apnea. by Oliveira, Flavia MS et al.
UCLA
UCLA Previously Published Works
Title
Abnormalities in autonomic function in obese boys at-risk for insulin resistance and 
obstructive sleep apnea.
Permalink
https://escholarship.org/uc/item/24v8f460
Journal
Pediatric research, 85(6)
ISSN
0031-3998
Authors
Oliveira, Flavia MS
Tran, Winston H
Lesser, Daniel J
et al.
Publication Date
2019-05-01
DOI
10.1038/s41390-018-0226-2
 
Peer reviewed
eScholarship.org Powered by the California Digital Library
University of California
ABNORMALITIES IN AUTONOMIC FUNCTION IN OBESE BOYS 
AT RISK FOR INSULIN RESISTANCE AND OBSTRUCTIVE SLEEP 
APNEA
Flavia M. S. Oliveira1, Winston H. Tran2, Daniel J. Lesser3, Rajeev Bhatia3, Thomas G. 
Keens3, Steven D. Mittelman4, Sally L. Davidson Ward3, and Michael C.K. Khoo2
1Department of Electrical Engineering, University of Brasilia, Brasilia, Brazil
2Department of Biomedical Engineering, University of Southern California, Los Angeles, 
California
3Division of Pediatric Pulmonology and Sleep Medicine, Children’s Hospital Los Angeles, Los 
Angeles, California
4Diabetes & Obesity Program, Center for Endocrinology, Diabetes & Metabolism, Children’s 
Hospital Los Angeles, Los Angeles, California
Abstract
Study Objectives: Current evidence in adults suggests that, independent of obesity, obstructive 
sleep apnea (OSA) can lead to autonomic dysfunction and impaired glucose metabolism, but these 
relationships are less clear in children. The purpose of this study was to investigate the 
associations among OSA, glucose metabolism and daytime autonomic function in obese pediatric 
subjects.
Methods: Twenty-three obese boys participated in: overnight polysomnography; a frequently 
sampled intravenous glucose tolerance test; and recordings of spontaneous cardiorespiratory data 
in both the supine (baseline) and standing (sympathetic stimulus) postures.
Results: Baseline systolic blood pressure and reactivity of low-frequency heart rate variability to 
postural stress correlated with insulin resistance, increased fasting glucose, and reduced beta cell 
function, but not OSA severity. Baroreflex sensitivity reactivity was reduced with sleep 
fragmentation, but only for subjects with low insulin sensitivity and/or low first-phase insulin 
response to glucose.
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Conclusions: These findings suggest that vascular sympathetic activity impairment is more 
strongly affected by metabolic dysfunction than by OSA severity, while blunted vagal autonomic 
function associated with sleep fragmentation in OSA is enhanced when metabolic dysfunction is 
also present.
Introduction
Obesity is considered to be a risk factor for hypertension and Type 2 diabetes, both of which 
predispose to cardiovascular disease (1). As well, obesity is a major risk factor for the 
development and progression of obstructive sleep apnea (OSA) (2). A growing body of 
evidence suggests that OSA itself can contribute independently to the development of 
systemic hypertension, coronary artery disease, heart failure and stroke (3, 4). More recently, 
many studies have pointed to an association between OSA and insulin resistance (IR), 
independent of obesity (5, 6). One factor that is common to obesity, OSA and IR is 
sympathetic nervous system overactivity (7). It remains unclear as to how these factors are 
causally connected, but it is likely that the vicious cycle of interplay among these factors 
predisposes to the emergence of “metabolic syndrome”, a convergence of obesity, 
hypertension, IR and dyslipidemia (8). This same constellation of factors is becoming more 
prevalent in children (9), increasing the risk for cardiovascular disease in the long term. In 
this regard, studies on obese children may provide better insights into the development of 
metabolic and autonomic dysfunction in OSA, due to the fact that children are less likely 
than adults, by virtue of age, to host co-morbidities that could confound measurements of 
cardiometabolic status. Nevertheless, to date, no comprehensive studies have yet been 
performed on the pediatric population to examine these associations in a single study, with 
the same patients.
The study hypothesis was that OSA indices and metabolic status are related to autonomic 
disorders, measured by heart rate variability and baroreflex sensitivity. In contradistinction 
to a number of similar studies that exist in the literature, our work investigated the 
associations among the three major factors in the same patients, who participated in a single 
study. Although prospective, longitudinal studies will ultimately be needed to definitively 
establish causal links, we postulated that careful quantitative analysis of the relationships 
linking measures of autonomic and metabolic function to OSA severity in the same pool of 
subjects would provide a useful foundation for future mechanistic studies.
Methods
Subjects
Twenty-three obese Latino male adolescents were recruited over a period of 24 months from 
the pool of patients referred to the Children’s Hospital Los Angeles (CHLA) Pulmonary 
Division for evaluation of snoring. Participants were required to be overweight or obese 
based on BMI Z-score and were otherwise healthy. Adolescence was defined as older than 
10 years. All subjects were recruited either after referral for polysomnography or to the 
pulmonary sleep clinic for a complaint of snoring with suspicion OSA. Exclusion criteria 
included a history of lung disease other than mild asthma not requiring inhaled 
corticosteroids, diabetes mellitus, hypertension requiring the use of antihypertensive 
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medications, use of stimulant medications, and positive airway treatment for OSA. Subjects 
completed an overnight polysomnography (PSG), a frequently-sampled intravenous glucose 
tolerance test (FSIVGTT), a dual-energy X-ray absorptiometry (DEXA) for assessing 
adiposity, and noninvasive measurement of respiration, heart rate (HR), and continuous 
blood pressure (BP) during the supine and standing postures. Only subjects that completed 
all components of the study were considered in the present investigation. A detailed 
description of the measurements of body fat, indexes of metabolic function, and 
polysomnography can be found in a previous paper (10).
Latino youth are at increased risk for the development of cardiovascular disease, type 2 
diabetes mellitus, and other complications of the metabolic syndrome (11). Studies 
investigating this population are limited (12). Moreover, since insulin resistance and 
compensatory insulin secretion vary with ethnicity and gender (12, 13), the current study 
was limited to obese adolescent Latino males to reduce the number of confounding 
variables. Furthermore, while the FSIVGTT allows a superior assessment of glucose 
homeostasis when compared to fasting values alone, the invasive nature of this test 
precluded the recruitment of healthy control subjects.
The experimental protocol was approved by the CHLA Institutional Review Board. Assent 
was obtained from each subject and written informed consent from the subject’s parents 
before participation in the study.
Indices of OSA severity
Overnight sleep parameters considered included the obstructive apnea hypopnea index 
(OAHI), the desaturation index (DESAT), and the total arousal index (TAI), per AASM 
scoring recommendations (14). The latter (TAI) includes both spontaneous and respiratory 
related arousals.
The AASM scoring recommendations show that there is still no consensus on the respiratory 
scoring rules to use for children between 13 and 18 years of age. In children, mild OSA is 
characterized by an OAHI between 1.5 and 5 events/hour, moderate OSA between 5 and 10 
events/hour, while severe OSA is characterized by OAHI greater than 10 events/hour (15, 
16). Based on these criteria, most of the subjects had mild apnea (16 cases, or 69.6%), 6 
(26.1%) had moderate to severe apnea, while 1 subject (4.3%) had primary snoring with an 
OAHI less than 1.5 events/hour. Since exclusion criteria included comorbidities such as 
asthma, diabetes, and systemic hypertension, potentially children with severe OSA were also 
excluded from the study. To divide our study population into “low” and “high” OAHI, we 
used the average of our study population (3 events/hour) as cutoff for OAHI. Using 5 events/
hour as cutoff did not significantly change our results.
Indices of metabolic function
To characterize the metabolic function of subjects, the following indices based on blood 
sampling obtained after overnight fasting were determined: (i) fasting plasma glucose 
concentration; (ii) insulin concentration levels; (iii) Homeostasis Model Assessment of 
Insulin Resistance index, or HOMAIR index, based on fasting blood glucose and insulin 
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levels (17, 18). High HOMAIR scores denote high insulin resistance (or, equivalently, low 
insulin sensitivity). To characterize the dynamics of glucose metabolism in the presence of 
insulin, frequently sampled intravenous glucose tolerance test (FSIVGTT) was employed, 
yielding accurate estimates of IR and also information about beta cell function (19, 20). The 
protocol adopted in this study was the insulin-modified FSIVGTT, consisting of timed blood 
samples after an overnight fast (12 hours). Glucose and insulin levels measured during the 
FSIVGTT were analyzed by a mathematical model of glucose homeostasis by insulin (21).
The metabolic parameters used to determine insulin-glucose physiology considered in this 
study, estimated from the FSIVGTT measurements, were: insulin sensitivity, SI 
(×10−4ml/min/μU), acute insulin response to glucose, AIRg (μU/ml×min), disposition index, 
DI (×10−4 / min), and glucose effectiveness, SG (min−1).
Indices of autonomic function
Indices of autonomic function were obtained for each subject in the daytime, consisting of 
contiguous 10-minute periods with measurements of airflow, continuous BP, and HR (ECG), 
initially in the supine (baseline) posture and, subsequently, while standing (orthostatic 
challenge as a sympathetic stimulus).
All patients were instructed to maintain their normal breathing pattern throughout the study. 
Airflow was measured via a pneumotachometer (model 3700, Hans Rudolph, Kansas City, 
MO) connected to a snug-fitting mask that covered the subjects’ nose and mouth. The 
variation of the lung volume over time was obtained from integration of airflow measured 
using the pneumotachograph connected to a differential pressure transducer (Validyne 
Model MP45-1-871 variable-reluctance transducer, from Validyne Engineering Corp., 
Northridge, CA). HR was monitored with a standard three-lead configuration and amplified 
using a BMA-200 bioamplifier, CWE Inc, Ardmore, PA. Systolic, mean, and diastolic BP 
signals were obtained from the continuous BP waveform recorded using a Nexfin HD 
monitor (BMEYE B. V., Amsterdam, the Netherlands).
With the subject in the supine posture for at least 5 minutes, the subject’s cuff BP was 
initially measured and the mean of three measurements taken at 1 minute intervals is used as 
reference. The mean of the BP measurements obtained from the Nexfin device during supine 
was adjusted to match the reference average cuff BP for each subject. Subsequently, 10 
minutes of data were recorded for determining baseline autonomic activity. The same 
variables were then recorded (10 minutes) with the subject in the standing posture, in order 
to elicit a shift of sympatho-vagal balance towards relative sympathetic dominance (22). 
Recording of the standing autonomic measurements began after the subject had assumed the 
upright posture for 5 minutes for hemodynamic equilibration.
Indices of the autonomic function determined from these measurements, for each posture, 
included: (a) mean R-R interval (mRRI); (b) mean systolic and diastolic BP (mSBP and 
mDBP, respectively); (c) low and high frequency power of RRI variability (RRILF and 
RRIHF, respectively); (d) the ratio of the low- to high-frequency power of RRI variability 
(RRILHR); (e) low and high frequency power of BP variability (SBPLF and SBPHF, 
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respectively); (f) the baroreflex sensitivity (BRS) index, both in the low and high frequency 
ranges (BRSLF and BRSHF, respectively).
BRS is an index of arterial baroreflex function (23). More specifically, it is a measure of a 
change in HR (or, more precisely in this study, its reciprocal, the R-to-R interval, RRI) per 
unit change in BP (systolic BP, SBP), in ms/mmHg. The higher the BRS index, the stronger 
the system’s response to a change in BP (23). In the present study, BRS was calculated as 
the square root of the ratio of the area under the curve of the RRI power spectrum by the 
area under the curve of the SBP power spectrum, both in the LF and HF regions (24):
BRSLF or HF =
RRI power LF or HF band
SBP power LF or HF band
Supine (baseline) vs. standing autonomic descriptors
Postural change from supine to standing was used as an autonomic challenge to elicit a shift 
in cardiac autonomic modulation from parasympathetic (supine) to sympathetic dominance 
(standing) (22). The autonomic HR variability (HRV), BP variability (BPV), and BRS 
indices were obtained from data collected in both the supine and standing postures. To 
quantify the autonomic reactivity to postural change, we used an autonomic reactivity index 
rRRI, defined as the ratio of the standing divided by the supine values, calculated for both 
low and high frequency components (rRRILF and rRRIHF, respectively), as well as for 
median RRI (rmRRI). A stand/supine ratio that is close to unity would represent low 
autonomic reactivity to orthostatic stress, whereas a ratio either much higher or much lower 
than unity would suggest a high autonomic reactivity. Similarly, a baroreflex reactivity 
index, rBRS, was used to quantify the BRS reactivity to postural change, in both the low and 
high frequency regions (rBRSLF and rBRSHF, respectively).
Statistical analyses
The study hypothesis was that OSA indices and metabolic status are related to autonomic 
disorders, measured by HR and BP variabilities and BRS indices calculated in the frequency 
domain. The variables considered in this study are listed in table 1. All variables were tested 
for normality (Kolmogorov-Smirnov test). Variables that were not normally distributed were 
log-transformed before analysis.
Analysis of Variance—Initially, one-way analysis of variance was used to test for 
difference in autonomic status, measured by the cardiovascular metrics listed in table 2, 
between different metabolic or sleep groups. The metabolic and sleep variables considered 
are listed in table 1. For this test, all independent variables were dichotomized at or near 
their medians, in order to divide the subjects into “low” and “high” sub-groups of roughly 
the same size. For example, our median cutoff for SI and DI are 2.3 and 2200, respectively, 
which is in accordance to the mean values for SI and DI found in Goran et al. (25) at 
baseline (2.31 and 2583, respectively).
Subsequently, two-way ANOVA tests with interaction were performed on each of the 
autonomic indices (SBP, DBP, mRRI, RRILF, RRIHF, RRILHR, SBPLF, SBPHF, or BRSLF, 
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BRSHF), in each posture (supine and standing, as well as the ratio stand/supine), with SDB 
(OAHI, TAI, or DESAT) and metabolic (SI, AIRg, DI, SG, fasting glucose, fasting insulin, 
or HOMAIR) status as the independent variables.
Multiple linear regression—The relationships between each of the autonomic indices 
and the potential explanatory variables (OSA and metabolic parameters), considering the 
influence of age and adiposity, were further investigated using multiple linear regression 
(MLR), with the following independent variables:
a. model A: OSA parameter, age, total % body fat
b. model B: metabolic index, age, total % body fat
c. model C: OSA parameter, metabolic index, age, total % body fat
For each model, the standardized regression coefficient βrel and its corresponding p-value, as 
well as the r2 statistic, were determined. The standardized regression coefficient βrel, with 
standardized units, quantifies the relative strength of each explanatory variable on the 
outcome (the autonomic measure considered) (26).
Finally, motivated by the fact that many two-way ANOVA with interaction tests showed a 
significant interaction term, a multiple regression analysis with interaction was performed, 
with centered predictors to avoid spurious regression effects (27).
Results
The characteristics of the subjects in all studies performed are displayed in Table 1.
HRV indices - spectral analysis
There were no significant associations between mean RRI or the HRV indices with supine or 
standing postures and either metabolic or OSA parameters. As well, no baseline autonomic 
index obtained from spectral analysis of HRV was found to be significantly associated with 
any sleep or metabolic measures, by any of the statistical tests evaluated (1-Way and 2-Way 
ANOVA, multiple regression analyses).
However, RRILHR increased significantly from supine to standing (p < 0.001) in all subjects, 
suggesting a shift in autonomic balance towards sympathetic dominance. Both mRRI and 
RRIHF for all subjects decreased in the standing relative to supine (p < 0.0001 in both cases, 
paired t-test, as shown in Table 2), implying decreased vagal modulation following 
orthostatic stress. The ratio rRRIHF was less than 1 for all subjects, indicating a decrease in 
vagal modulation upon standing, as expected. The ratio rmRRI was also < 1 for all subjects, 
indicating increased median HR in the standing posture compared to baseline. The shorter 
R-R intervals (or higher HR) in the standing posture are consistent with a decrease in 
parasympathetic modulation (22).
Standard MLR analysis found the log-transformed rRRILF ratio to be positively correlated 
with log(SI), but not with any of the OSA parameters. Figure 1 shows the plot for the 
regression of SI on the ratio rRRILF, adjusted for age and adiposity. Subjects with higher SI 
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values (above 5) have mostly an rRRILF ratio > 1 while those with low SI values (less than 
5) predominantly have a rRRILF ratio < 1.
BP and BPV
DBP increased significantly from supine to standing, whle SBP remained unchanged, 
consistent with what has been previously reported (28). In terms of the BPV indices, both 
low and high frequency components (SBPLF and SBPHF, respectively) increased from 
supine to standing. The increase in SBPLF could be an indication of increased sympathetic 
modulation of peripheral vasculature, whereas the increase in SBPHF may have been due to 
enhanced respiratory modulation of the contractility of the heart (29, 30) during standing.
Comparing SBPsup (baseline) between different metabolic or sleep groups, SBPsup was 
higher in subjects with insulin resistance, defined by low SI and elevated fasting glucose and 
HOMAIR values (all p < 0.02, one-way ANOVA). However, SBPsup was not affected by 
OSA parameters, such as OAHI, TAI or DESAT (p > 0.05 for all comparisons, one-way 
ANOVA). Two-way ANOVA and MLR analyses, including both metabolic and OSA indices 
as independent variables confirmed these results. Table 3 presents the results of the 
significant MLR analyses, including the standardized regression coefficient βrel and its 
corresponding p-value, for SBPsup as the dependent variable. Figure 2 shows the scatter plot 
and regression line of SBPsup vs. SI, while Figure 3 shows the results for SBPsup vs. fasting 
glucose, both adjusted for age and total % body fat. The MLR tests showed an increase in 
SBPsup with lower disposition index (DI) levels, but not with any of the sleep parameters 
analyzed. There was no significant association between any of the OSA severity indices or 
any of the metabolic indices and the low and high frequency components of BPV (SBPLF 
and SBPHF, respectively) or the BP reactivity indices (stand-to-supine ratios, in either 
frequency range).
Baroreflex sensitivity (BRS)
No association was found in BRSLF and BRSHF (in both supine and standing) among 
different metabolic or sleep groups (using either ANOVA or regression analyses). However, 
both BRSLF and BRSHF decreased from supine to standing.
The reactivity index, rBRSHF, increased with sleep fragmentation, as measured by TAI, 
indicating a reduced baroreflex reactivity to postural stress with increased TAI (p < 0.01 for 
both one- and two-way ANOVA), while no main effect was observed for any metabolic 
index (p > 0.05, both one- and two-way ANOVA). Nevertheless, a post hoc analysis using 
Tukey’s procedure further revealed that, for those subjects with low SI, a higher sleep 
fragmentation (as measured by TAI) is associated with a decreased BRSHF reactivity to 
postural change. No difference in rBRSHF was found in the high SI group. Since all subjects 
showed decreases in BRSHF and BRSLF with postural change, indicating a decreased 
baroreflex sensitivity in the standing posture, all rBRS stand-to-supine ratios were < 1. 
However, a higher ratio (an rBRS value closer to 1) indicates a smaller degree of change 
from supine to standing, suggesting a decreased BRS reactivity to postural change. This 
result is illustrated in Figure 4(a).
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Similarly, while no main effect was observed for AIRg (p = 0.17, two-way ANOVA), a post 
hoc pairwise multiple comparison using Tukey’s procedure further revealed that, within the 
low AIRg group, an increase in TAI was associated with a decreased BRS reactivity to 
postural stress (measured as an increased rBRSHF ratio). No significant association was 
found in the high AIRg group (see Figure 4(b)). The results in Figure 4 were also 
corroborated by MLR analysis.
Discussion
While previous studies examined the associations between HRV and OSA severity (31, 32, 
33), and between metabolic function and OSA severity (10,34), this study is the first to have 
measured all 3 factors – metabolic, autonomic and sleep – in the same subjects, using a 
variety of metrics to better characterize each factor. Moreover, this is the first study of its 
kind in a pediatric population, and follows an earlier report by our group that impaired 
glucose homeostasis in obese adolescents is correlated to sleep fragmentation and episodic 
hypoxemia (10). In this study, we employed a comprehensive battery of noninvasive 
measures of autonomic function, derived from HRV and BPV and their responses to 
orthostatic stress, as well as precise measures characterizing the dynamics of glucose-insulin 
regulation derived from the FSIVGTT in a relatively homogeneous group of otherwise 
healthy adolescent males with well characterized PSG parameters.
Our key findings may be summarized as follows:
1. Reactivity of low-frequency HRV (rRRILF) to orthostatic stress was correlated 
with insulin sensitivity, independent of OSA severity.
2. Baseline (supine) systolic BP (SBPsup) was higher in subjects with metabolic 
indices consistent with lower SI, greater IR (higher HOMAIR), increased fasting 
glucose, and reduced beta-cell function (lower DI), independent of OSA severity.
3. Reactivity of baroreflex sensitivity to orthostatic stress was reduced with greater 
sleep fragmentation (as measured by arousal frequency), but only in those 
subjects with low SI and/or low first-phase insulin response to glucose (AIRg).
Figure 5 provides a schematic illustration of these key findings, along with those from our 
previous study (10), highlighting the interactions among the metabolic, autonomic and sleep 
regulation systems.
HRV and metabolic function
To better understand the meaning and implications of the above findings, it is important to 
review what is commonly accepted about the autonomic indices we extracted from 
noninvasive measurements of beat-to-beat RRI and BP. The spectral (frequency-based) 
content of HRV is commonly used to deduce useful information about the vagal and 
sympathetic contributions to HR modulation. RRIHF is generally ascribed to vagal 
modulation, whereas there is consensus that RRILF represents a combination of sympathetic 
and vagal modulation. The ratio of RRILF to RRIHF (= RRILHR) is generally referred to as 
the index representing “sympathovagal balance”. However, a high RRILHR could imply 
sympathetic-over-vagal dominance, or it could also reflect parasympathetic withdrawal with 
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little contribution from the sympathetic branch. HRV indices measured during baseline 
conditions in the supine posture are expected to reflect parasympathetic dominance; during 
standing, the sympathetic activity increases while vagal or parasympathetic activity 
decreases. Our subjects indeed exhibited a significant vagal withdrawal during standing 
compared to supine, as indicated by a decrease in mRRI and RRIHF, and an increase in the 
ratio RRILHR, reflecting a shift to sympathetic dominance from supine to standing (Table 2). 
On the other hand, the change in RRILF from supine to standing was not significant. This 
may be explained by the fact that orthostatic stress leads to parasympathetic withdrawal 
(which decreases RRILF) and sympathetic excitation (which increases RRILF); thus, whether 
there is a net increase or decrease in RRILF, depends on which autonomic branch contributes 
more to the change in HRV following postural change.
None of the measures of HRV under baseline or standing conditions in our subjects were 
associated with any metabolic or OSA index. This could have been due to the high degree of 
inter-subject variability in these HRV indices, while none of the subjects had severe 
manifestations of metabolic dysfunction or OSA. As such, we turned to the “reactivity” 
indices instead, since these reflect changes in HRV in response to a strong autonomic 
stimulus (orthostatic stress) and therefore may have been more sensitive to metabolic or 
OSA effects. What stood out was the positive correlation between rRRILF (the reactivity 
index of RRILF to orthostatic stress) and SI (Fig.1). Subjects with high SI tended to have 
rRRILF close to or greater than unity (and thus a net increase in RRILF from supine to 
standing), suggesting that these subjects had a more robust sympathetic contribution to the 
HR response to orthostatic stress. In contrast, in subjects with low SI, the increase in HR 
accompanying standing was likely dominated by vagal withdrawal – hence the net decrease 
in RRILF. A potential explanation is that, in subjects with low SI, the overall sympathetic 
contribution to HRV was already high – thus, orthostatic stress was less likely to elicit 
greater sympathetic modulation of HR.
BP and metabolic function
Although none of our subjects were diagnosed with Type 2 diabetes and all presented fasting 
glucose levels within the normal range (≤ 100 mg/dl), higher baseline SBPsup was correlated 
with higher fasting glucose, higher IR (as measured by the HOMAIR index), lower SI, and 
lower DI, all components of the metabolic syndrome (20). Given that there was no 
correlation between mRRI (or equivalently, mean HR) and any of the metabolic indices, we 
speculate that total peripheral resistance was the likely driver of the relationship between 
SBPsup and insulin resistance. This further suggests that subjects with low SI and higher 
fasting glucose probably had increased peripheral vascular sympathetic tone. Surprisingly, 
we found no independent correlation between BP and OSA severity, suggesting that the 
elevated peripheral vascular sympathetic activity in the subjects we studied was more likely 
the result of metabolic dysfunction than their OSA per se.
Baroreflex reactivity and metabolic-sleep interaction
While baseline (supine) systolic BP and reactivity of low-frequency HRV (rRRILF) 
correlated with the factors associated with the metabolic syndrome, but not to any measure 
of OSA severity, a third measure of autonomic function, the reactivity of BRS to orthostatic 
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stress (rBRSHF), was correlated with sleep fragmentation (as measured by TAI). More 
importantly, our findings reveal that this rBRSHF–TAI correlation was only present in those 
subjects with low SI and/or low first-phase insulin response to glucose (AIRg), both 
manifestations of metabolic dysfunction. A number of previous studies have reported a 
blunted BRS in subjects with OSA (35, 36, 37), but these studies did not control for 
metabolic conditions. Since baroreflex sensitivity is believed to be a reliable measure of 
vagal tone (38), we interpret this result to indicate that sleep fragmentation leads to blunting 
of vagal reactivity to orthostatic stress in subjects with high IR and/or low AIRg. It has been 
well documented that arousals from sleep are generally accompanied by surges of 
sympathetic activity; thus, it is conceivable that blunting of vagal reactivity could result from 
cumulative exposure to these sympathetic bursts that occur with high frequency night after 
night.
Inferences from the findings
As summarized in Figure 5, the key findings of this study and our previous report (10) on 
obese adolescents with OSA point to: (a) a strong association between measures of 
autonomic and metabolic function; (b) a robust association between measures of OSA 
severity and glucose metabolism; and (c) an association between autonomic function and 
OSA severity that is weak in subjects with metabolic health but enhanced in subjects with 
impaired glucose metabolism. This interaction between metabolic health and OSA severity 
has also been reported by Koren et al. (39). In a study with both obese and nonobese 
children, the authors found that OSA severity, as measured by AHI, was associated with 
obesity, but only for those subjects who were more insulin resistant. However, this study did 
not measure autonomic function. The results from our study are also consistent with those of 
Cerutti et al. (40) in which oral glucose tolerance tests were conducted and HRV was 
measured in 3 categories of subjects: obese girls with Type 2 diabetes, obese girls with no 
family history of diabetes, and lean age-matched controls.. However, Cerutti and colleagues 
did not include indices of sleep or OSA as a third factor. Peltier and colleagues (41) found 
no differences in autonomic cardiovascular stress test results in adults with OSA versus 
subjects without OSA. However, when the same pool of subjects was divided into those who 
had impaired glucose regulation and those with normal glucose metabolism, the former 
group demonstrated impaired autonomic function. In overweight adult subjects with and 
without OSA, Wang et al. (42) found that HRV and BRS determined from the 
polysomnogram across sleep stages correlated with the degree of glucose intolerance but not 
with the severity of OSA. These studies suggest that in overweight or obese subjects, 
metabolic dysfunction is the primary driver of autonomic imbalance, with OSA severity 
playing a secondary role. Insulin infusion has been shown to increase muscle sympathetic 
nerve activity (MSNA) in healthy and borderline hypertensive subjects (43,44), while 
treatment of hypertension does not reverse the IR (45). Thus, hyperinsulinemia, secondary to 
IR, appears to be the key driver of sympathetic overactivity.
The cross-sectional nature of our study does not permit a definitive conclusion on the 
causalities to explain the associations found among the variables investigated. Longitudinal 
studies with larger cohorts and carefully designed interventions are necessary to confirm our 
results. Nevertheless, taken together with other studies, our findings suggest that there is a 
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need to control for metabolic conditions in investigations examining the contribution of OSA 
to autonomic dysfunction. Since most previous studies investigating cardiovascular 
autonomic function in OSA did not measure glucose or insulin, it is highly possible that the 
abnormalities in autonomic function reported in these studies were more directly related to 
metabolic derangements than to the repetitive arousals or intermittent hypoxia in OSA.
Conclusions
Our findings suggest that increased peripheral vascular sympathetic activity (indicated by 
increased baseline SBP) and reduced vagal autonomic reactivity to postural stress (as 
measured by rRRILF) are associated with manifestations of the metabolic syndrome, such as 
higher fasting glucose, higher insulin resistance, lower insulin sensitivity, and decreased 
compensatory β-cell function, but not with the severity of OSA. In other words, impairment 
of the sympathetic limb of autonomic function is more strongly affected by the level of 
metabolic dysfunction than by the severity of OSA in pediatric obesity. We speculate that 
metabolic dysfunction may be the initial entry point paving the way for other co-morbidities 
and thus provides an important early target for treatments in order to modify the progression 
of disease in obesity. Additionally, the ratio rBRSHF, related to vagal activity, was found to 
be negatively associated with sleep fragmentation present in OSA, but only for those 
subjects with low SI and low AIRg, both components of the metabolic syndrome. Thus, 
impairment in vagal reactivity to orthostatic stress in OSA is worsened when metabolic 
dysfunction is also present. The strong association with metabolic dysfunction suggests that 
the measurement of the autonomic reactivity to postural stress may be useful as a 
complementary noninvasive means for the early detection of the metabolic syndrome in 
young at-risk.
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Abbreviation
OAHI Obstructive apnea-hypopnea index (n/h)
DESAT Desaturation Index (n/h)
TAI Total Arousal Index (n/h)
SI Insulin sensitivity (mU/l)−1 min−1
AIRg Acute insulin response to glucose (mU/l) min
DI Disposition index (SI 0078 AIRg)
SG Glucose effectiveness (x 10−2 min−1)
HOMAIR Homeostasis model assessment of insulin resistance index
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RRI R-to-R interval of the ECG (ms)
mRRI Mean R-R interval (ms)
RRILF, RRIHF Low and high frequency power of R-R interval variability, 
respectively (ms2)
RRILHR The ratio of the low- to high-frequency power of R-R 
interval variability
rRRI Autonomic reactivity index, defined as the ratio of the 
standing RRI divided by the supine values of RRI, used to 
quantify the autonomic reactivity to postural change
rRRILF, rRRIHF Low and high frequency components of the ratio rRRI, 
respectively
rmRRI The ratio (standing/supine) rRRI calculated for median 
RRI
mSBP Systolic blood pressure (mmHg)
mDBP Diastolic blood pressure (mmHg)
BRS Baroreflex sensitivity index (ms/mmHg)
BRSLF, BRSHF Low and high frequency components of the BRS index, 
respectively (ms/mmHg)
rBRS Baroreflex reactivity index, defined as the ratio of the 
standing divided by the supine BRS, used to quantify the 
BRS reactivity to postural change
rBRSLF, rBRSHF Low and high frequency components of the ratio rBRS, 
respectively
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Figure 1: 
rRRILF* ratio (adjusted for age and total % body fat) vs SI
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Figure 2: 
SBPsup* (adjusted for age and total % body fat) vs SI
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Figure 3: 
SBPsup* (adjusted for age and total % body fat) vs Fasting Glucose
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Figure 4: 
Two-way ANOVA with interaction on rBRSHF for low and high TAI and (a) low and high SI 
and (b) low and high AIRg groups.
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Figure 5: 
Diagram illustrating the interactions found between autonomic function, OSA severity, and 
metabolic function. As mentioned in the text, the association between the reactivity index 
rRRILF and SI suggests sympathetic autonomic dysfunction to orthostatic stress 
predominantly for subjects with SI < 5 (mU/l)−1 min−1. Likewise, the association between 
increased sleep fragmentation and decreased vagal reactivity to postural stress (rBRSHF) was 
found to be significant only for those subjects with low insulin sensitivity (SI) and/or low 
acute first-phase insulin response to glucose (AIRg).
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Table 1:
Demographic, sleep, metabolic, and autonomic characteristics
Variable (n = 23) (mean ± SD) Range
Demographic/Anthropomorphic
Age (years) 13.5 ± 2.2 10.3 – 17.8
BMI* (kg/m2) 34.0 ± 6.3 25.3 – 52.5
BMI (z-Score) 2.4 ± 0.31 2.0 – 3.2
Total body fat (kg) 35.9 ± 11.9 18.8 – 63.6
Total % body fat 40.7 ± 4.9 29.9 – 50.0
Trunk fat (g) 16.1 ± 4.8 8.9 – 25.9
Trunk % fat 40.6 ± 4.4 30.9 – 46.0
Polysomnography
Obstructive AHI** (n/h) 4.1 ± 3.1 1.0 – 14.1
Desaturation Index (n/h) 8.2 ± 10.0 0.1 – 40.1
Total Arousal Index (n/h) 11.5 ± 6.6 4.1 – 29.0
Metabolic
SI (mU/l)−1 min−1 3.9 ± 4.7 0.9 – 22.2
AIRg (mU/l) min 1076±842 147 – 3360
DI (SI × AIRg) 2593 ±1735 537 – 8328
SG × 10−2 min−1 0.0202 ± 0.0085 0.0030 – 0.0387
Fasting Glucose (mg/dl) 84.3 ± 6.7 70.5 – 100.0
Fasting Insulin (μ,U/ml) 12.9 ± 6.7 2.0 – 26.0
HOMAIR 2.73 ± 1.47 0.40 – 5.22
Cardiovascular measures
RRI (baseline), ms 851.1 ± 129.0 596.8 – 1094.0
Heart Rate (baseline), beats/min 72.6 ± 12.0 55.6 – 100.7
SBP (baseline), mmHg 121.9 ± 15.9 98.3 – 151.6
DBP (baseline), mmHg 60.8 ± 8.0 49.2 – 74.2
RRILF (baseline), ms2 779.3 ± 561.8 145.6 – 2444.1
RRIHF (baseline), ms2 2261.3 ± 2394.9 44.1 – 9090.8
BRSLF (baseline), ms/mmHg 10.0 ± 3.4 3.5 – 16.0
BRSHF (baseline), ms/mmHg 28.5 ± 22.1 3.0 – 83.0
*
BMI ≥ 90th percentile for age and gender
**AHI: apnea hypopnea index. Upper limit of normal in this age group = 1.5 events/h
Exclusion criteria: diabetes, systemic hypertension, and treatment for OSA
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Table 2:
Descriptive statistics of cardiovascular variables used to quantify autonomic characteristics
Cardiovascular measures (n = 
23)
Supine (mean + SD) if normally distr. or 
median (Q1 – Q3) otherwise
Standing (mean + SD) if normally distr. 
or median (Q1 – Q3) otherwise p-value
mRRI, ms 851.1 ± 129.0 643.0 ± 91.1 p < 0.0001
Heart Rate, beats/min 72.6 ± 12.0 95.5 ± 12.8 p < 0.0001
SBP, mmHg 121.9 + 15.9 125.8 + 23.8 p = 0.30 (n.s.)
DBP, mmHg 60.8 ± 8.0 73.5 ± 12.5 p < 0.0001
RRILF, ms2 657.1 (443.6 – 893.5) 606.8 (369.0 – 933.4) p = 0.19 (n.s.)
RRIHF, ms2 1622.9 (637.2 – 2522.9) 215.3 (119.7 – 488.3) p < 0.0001
RRILHR, ms2 0.425 (0.209 – 1.199) 2.536 (1.560 – 4.546) p < 0.001
SBPLF, mmHg2 6.6 (4.7 – 12.0) 15.9 (9.7 – 35.7) p < 0.001
SBPHF, mmHg2 3.7 ± 3.2 9.6 ± 6.3 p < 0.001
BRSLF, ms/mmHg 10.3 (6.9 – 12.2) 5.8 (3.3 – 7.7) p < 0.001
BRSHF, ms/mmHg 21.6 (12.3 – 37.4) 6.8 (3.0 – 8.8) p < 0.0001
Significantly different values (p < 0.05) due to change in posture are shown in bold. (n.s.): not significant.
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Table 3:
Results of additive multiple linear regression analysis using the 3 models previously described (seeMethods 
section), for SBPsup as the dependent variablea
Dependent variable
Regression models
A (OSA parameter, age, total % body fat) B (metabolic index, age, total % body fat) C (OSA parameter, metabolic 
index, age, total % body fat)
Explanatory Variables Standard. βrel (p-
value) [R2]
Explanatory variables Standard. βrel (p-
value) [R2]
Explanatory variables βrel_OSA 
(p), 
βrel_met 
(p) [R2]
SBPsup log(DESAT) 0.010 (0.97) [0.262] log(SI)* −0.413 (0.046) [0.410] log(DESAT), log(si)* −0.171 
(0.46), 
−0.466 
(0.035) 
[0.427]
SBPsup log(OAHI) 0.151 (0.45) [0.173] FastGluc* 0.443 (0.020) [0.449] log(OAHI), FastGluc* 0.087 
(0.631), 
0.430 
(0.028) 
[0.464]
SBPsup log(DESAT) 0.010 (0.97) [0.262] FastGluc* 0.442 (0.020) [0.449] log(DESAT), FastGluc* −0.013 
(0.95), 
0.443 
(0.024) 
[0.449]
SBPsup log(DESAT) 0.010 (0.97) [0.262] log(DI)* −0.408 (0.036) [0.418] log(DESAT), log(DI)* −0.0092 
(0.97), 
−0.408 
(0.042) 
[0.418]
SBPsup log(DESAT) 0.010 (0.97) [0.262] HOMAIR* 0.391 (0.041) [0.411] log(DESAT), HOMAIR* −0.0501 
(0.82), 
0.396 
(0.045) 
[0.413]
a
P values are shown in bold if p ≤ 0.05 or italics if 0.05 < p < 0.1.
Significant explanatory variables are indicated with an asterisk (*). All models have been adjusted for age and adiposity (total % body fat).
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